BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11605181)

  • 21. Early-stage non-small-cell lung cancer: adjuvant versus neoadjuvant chemotherapy.
    Belani CP
    Clin Lung Cancer; 2003 Jul; 5(1):11-2. PubMed ID: 14596696
    [No Abstract]   [Full Text] [Related]  

  • 22. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.
    Albain KS; Rusch VW; Crowley JJ; Rice TW; Turrisi AT; Weick JK; Lonchyna VA; Presant CA; McKenna RJ; Gandara DR
    J Clin Oncol; 1995 Aug; 13(8):1880-92. PubMed ID: 7636530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.
    Keller SM; Adak S; Wagner H; Herskovic A; Komaki R; Brooks BJ; Perry MC; Livingston RB; Johnson DH
    N Engl J Med; 2000 Oct; 343(17):1217-22. PubMed ID: 11071672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer.
    Bernstein ED; Herbert SM; Hanna NH
    Ann Surg Oncol; 2006 Mar; 13(3):291-301. PubMed ID: 16450219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of docetaxel (Taxotere) as a single agent or in combination before local treatment of non-small cell lung cancer.
    Harper P
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-30-S14-32. PubMed ID: 9335522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial of mitomycin/ifosfamide/cisplatin preoperative chemotherapy plus surgery versus surgery alone in stage IIIA non-small cell lung cancer.
    Rosell R; Maestre J; Font A; Moreno I; Molina F; Milla A; Gómez-Codina J; Camps C
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):28-33. PubMed ID: 8209274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative chemotherapy for non-small cell lung cancer.
    Depierre A; Westeel V; Jacoulet P
    Cancer Treat Rev; 2001 Apr; 27(2):119-27. PubMed ID: 11319850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy for non-small-cell lung cancer. Part 1: Early-stage disease.
    Novello S; Le Chevalier T
    Oncology (Williston Park); 2003 Mar; 17(3):357-64. PubMed ID: 12661267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preoperative induction chemotherapy for unresectable stage IIIA non-small-cell lung cancer].
    Wang SY; Zeng ZF; Ou W; Lin YB; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):747-9. PubMed ID: 16483489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neoadjuvant chemotherapy in non-small cell lung cancer: current state and future].
    Mellas N; Elmesbahi O; Masbah O; Errihani H
    Bull Cancer; 2010 Feb; 97(2):211-23. PubMed ID: 20051349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].
    Cheng C; Wu YL; Gu LJ; Chen G; Weng YM; Feng WN; Zhong WZ
    Ai Zheng; 2005 Jul; 24(7):846-9. PubMed ID: 16004813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of chemotherapy in stages I to III non-small cell lung cancer.
    Strauss GM
    Chest; 1999 Dec; 116(6 Suppl):509S-516S. PubMed ID: 10619521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy for non-small-cell lung carcinoma: from a blanket approach to individual therapy.
    Reungwetwattana T; Eadens MJ; Molina JR
    Semin Respir Crit Care Med; 2011 Feb; 32(1):78-93. PubMed ID: 21500127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgery following neoadjuvant MPV chemotherapy (mitomycin, cisplatin, vinblastine) in locally advanced (IIIa and IIIb) non-small cell lung cancer.
    Carretta A; Chiesa G; Zannini P; Villa E; Verusio C; Fumagalli F; Melloni G; Grossi A
    Eur J Cardiothorac Surg; 1994; 8(9):457-61. PubMed ID: 7811477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Is there a place for surgical management in stage IIIA N2 non-small cell lung cancer?].
    Pagès PB; Pforr A; Delpy JP; Abou Hanna H; Bernard A
    Rev Mal Respir; 2015 May; 32(5):485-92. PubMed ID: 25498767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete response following preoperative chemotherapy for resectable non-small cell lung cancer: accuracy of clinical assessment using the French trial database.
    Milleron B; Westeel V; Quoix E; Moro-Sibilot D; Braun D; Lebeau B; Depierre A;
    Chest; 2005 Sep; 128(3):1442-7. PubMed ID: 16162741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current management of unresectable non-small cell lung cancer.
    Livingston RB
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):4-11; discussion 11-3. PubMed ID: 7973768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial.
    de Boer RH; Smith IE; Pastorino U; O'Brien ME; Ramage F; Ashley S; Goldstraw P
    Br J Cancer; 1999 Mar; 79(9-10):1514-8. PubMed ID: 10188899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of non-small cell lung cancer according to staging--an update.
    Lam WK
    Respirology; 1998 Mar; 3(1):51-4. PubMed ID: 9657661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer.
    Roberts JR; Eustis C; Devore R; Carbone D; Choy H; Johnson D
    Ann Thorac Surg; 2001 Sep; 72(3):885-8. PubMed ID: 11565675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.